• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

穿透性角膜移植术之前、期间或之后进行的同种异体管分流手术的结果。

Results of alloplastic tube shunt procedures before, during, or after penetrating keratoplasty.

作者信息

Rapuano C J, Schmidt C M, Cohen E J, Rajpal R K, Raber I M, Katz L J, Wilson R P, Laibson P R, Kremer I

机构信息

Cornea Service, Wills Eye Hospital, Philadelphia, PA 19107.

出版信息

Cornea. 1995 Jan;14(1):26-32.

PMID:7712732
Abstract

The association of glaucoma and penetrating keratoplasty presents a difficult management problem, particularly when medical therapy and conventional glaucoma surgery have failed. We have found alloplastic tube shunt surgery to be an effective method for intraocular pressure control in glaucomatous eyes subjected to penetrating keratoplasty. We report 46 patients who underwent alloplastic tube shunt implantation before (13 patients, group A), in combination with (17 patients, group B), or after (16 patients, group C) penetrating keratoplasty. All groups had significantly lowered intraocular pressure postoperatively. The most common complication was graft failure, in 31% of patients in group A, 29% in group B, and 44% in group C. Other postoperative complications and results including visual outcome are reviewed. Because the management of advanced glaucoma in patients undergoing keratoplasty is difficult, alloplastic tube shunt implantation should be considered.

摘要

青光眼与穿透性角膜移植的关联带来了棘手的治疗难题,尤其是在药物治疗和传统青光眼手术均告失败之时。我们发现,对于接受穿透性角膜移植的青光眼患者,异体材料管分流手术是控制眼压的有效方法。我们报告了46例患者,他们在穿透性角膜移植术前(13例,A组)、术中(17例,B组)或术后(16例,C组)接受了异体材料管分流植入术。所有组术后眼压均显著降低。最常见的并发症是植片失败,A组31%的患者、B组29%的患者以及C组44%的患者出现了该并发症。还对包括视力转归在内的其他术后并发症及结果进行了回顾。由于角膜移植患者晚期青光眼的治疗难度较大,应考虑行异体材料管分流植入术。

相似文献

1
Results of alloplastic tube shunt procedures before, during, or after penetrating keratoplasty.穿透性角膜移植术之前、期间或之后进行的同种异体管分流手术的结果。
Cornea. 1995 Jan;14(1):26-32.
2
Comparison of mitomycin C trabeculectomy, glaucoma drainage device implantation, and laser neodymium:YAG cyclophotocoagulation in the management of intractable glaucoma after penetrating keratoplasty.穿透性角膜移植术后难治性青光眼治疗中丝裂霉素C小梁切除术、青光眼引流装置植入术及激光钕:钇铝石榴石睫状体光凝术的比较
Ophthalmology. 1998 Aug;105(8):1550-6. doi: 10.1016/S0161-6420(98)98046-0.
3
Surgical management of glaucoma in infants and children with Peters' anomaly: long-term structural and functional outcome.彼得斯异常患儿青光眼的手术治疗:长期结构和功能转归
Ophthalmology. 2004 Jan;111(1):112-7. doi: 10.1016/j.ophtha.2003.02.002.
4
Drainage tube implants in the treatment of glaucoma following penetrating keratoplasty.引流管植入术在穿透性角膜移植术后青光眼治疗中的应用
Ophthalmic Surg. 1993 Mar;24(3):185-9.
5
[Shunt tube implantation combining amniotic membrane transplantation and implantation of Molteno implant for glaucoma after penetrating keratoplasty].穿透性角膜移植术后青光眼行分流管植入联合羊膜移植及莫尔顿植入物植入术
Yan Ke Xue Bao. 2000 Jun;16(2):65-72.
6
Incidence of and risk factors for increased intraocular pressure after penetrating keratoplasty.穿透性角膜移植术后眼压升高的发生率及危险因素。
Cornea. 2010 Mar;29(3):278-82. doi: 10.1097/ICO.0b013e3181b6eb9e.
7
Combined penetrating keratoplasty and trabeculectomy with mitomycin C.穿透性角膜移植术联合丝裂霉素C小梁切除术
Ophthalmology. 1999 Feb;106(2):396-400. doi: 10.1016/S0161-6420(99)90081-7.
8
Long-term results of Molteno implants.莫尔托诺植入物的长期效果。
Ophthalmic Surg. 1995 Mar-Apr;26(2):130-5.
9
[Incidence and factors influencing glaucoma after penetrating keratoplasty].[穿透性角膜移植术后青光眼的发病率及影响因素]
J Fr Ophtalmol. 2003 Jun;26(6):553-61.
10
Penetrating keratoplasty with pars plana glaucoma drainage devices.穿透性角膜移植联合玻璃体平坦部青光眼引流装置
Cornea. 2007 Oct;26(9):1060-6. doi: 10.1097/ICO.0b013e3181342835.

引用本文的文献

1
Clinical Factors Impacting Outcomes From Failed Trabeculectomy Leading to Glaucoma Drainage Device Implantation and Subsequent Penetrating Keratoplasty.影响青光眼引流装置植入及后续穿透性角膜移植术后失败的小梁切除术结果的临床因素。
J Glaucoma. 2023 Sep 1;32(9):800-806. doi: 10.1097/IJG.0000000000002239. Epub 2023 May 12.
2
Minimally Invasive Surgery in Mild-to-Moderate Glaucoma Patients in Italy: Is It Time to Change?意大利轻度至中度青光眼患者的微创手术:是时候做出改变了吗?
Clin Ophthalmol. 2020 Sep 14;14:2639-2655. doi: 10.2147/OPTH.S264839. eCollection 2020.
3
Baerveldt surgery outcomes: anterior chamber insertion versus vitreous cavity insertion.
贝尔维尔德手术结果:前房植入与玻璃体腔植入
Graefes Arch Clin Exp Ophthalmol. 2018 Nov;256(11):2191-2200. doi: 10.1007/s00417-018-4116-4. Epub 2018 Aug 31.
4
Glaucoma after penetrating keratoplasty.穿透性角膜移植术后青光眼
Rom J Ophthalmol. 2017 Jul-Sep;61(3):159-165. doi: 10.22336/rjo.2017.30.
5
Outcome of primary trabeculotomy ab interno (Trabectome) surgery in patients with steroid-induced glaucoma.原发性内路小梁切开术(Trabectome)治疗激素性青光眼患者的疗效
Medicine (Baltimore). 2016 Dec;95(50):e5383. doi: 10.1097/MD.0000000000005383.
6
Factors associated with graft survival and endothelial cell density after Descemet's stripping automated endothelial keratoplasty.Descemet膜剥脱自动角膜内皮移植术后与移植物存活及内皮细胞密度相关的因素。
Sci Rep. 2016 Apr 28;6:25276. doi: 10.1038/srep25276.
7
Clinical outcomes after combined Ahmed glaucoma valve implantation and penetrating keratoplasty or pars plana vitrectomy.Ahmed青光眼阀植入联合穿透性角膜移植术或玻璃体切除术的临床疗效。
Korean J Ophthalmol. 2012 Dec;26(6):432-7. doi: 10.3341/kjo.2012.26.6.432. Epub 2012 Nov 12.
8
Endothelial graft failure after contralateral autologous corneal transplantation.对侧自体角膜移植后内皮移植物失功。
Cornea. 2013 Jun;32(6):745-50. doi: 10.1097/ICO.0b013e31826dff17.
9
Early Ahmed glaucoma valve implantation after penetrating keratoplasty leads to better outcomes in an Asian population with preexisting glaucoma.穿透性角膜移植术后早期行 Ahmed 青光眼阀植入术可改善亚洲青光眼患者的预后。
PLoS One. 2012;7(5):e37867. doi: 10.1371/journal.pone.0037867. Epub 2012 May 21.
10
Five-year outcomes of eyes with glaucoma drainage device and penetrating keratoplasty.青光眼引流装置和穿透性角膜移植术后 5 年的结果。
J Glaucoma. 2012 Dec;21(9):608-14. doi: 10.1097/IJG.0b013e31821db3e5.